Arrowhead Pharmaceuticals Stock Beta

ARWR Stock  USD 23.29  0.49  2.06%   
Arrowhead Pharmaceuticals fundamentals help investors to digest information that contributes to Arrowhead Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Arrowhead Stock. The fundamental analysis module provides a way to measure Arrowhead Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arrowhead Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Arrowhead Pharmaceuticals Company Beta Analysis

Arrowhead Pharmaceuticals' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Arrowhead Pharmaceuticals Beta

    
  0.72  
Most of Arrowhead Pharmaceuticals' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arrowhead Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Arrowhead Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Arrowhead Pharmaceuticals is extremely important. It helps to project a fair market value of Arrowhead Stock properly, considering its historical fundamentals such as Beta. Since Arrowhead Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Arrowhead Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Arrowhead Pharmaceuticals' interrelated accounts and indicators.
0.780.04-0.920.790.240.920.530.740.260.360.620.830.20.970.030.770.420.980.26-0.220.930.110.720.720.26
0.78-0.4-0.630.540.370.480.640.51-0.140.390.550.480.250.660.170.80.370.740.26-0.30.720.160.950.69-0.14
0.04-0.4-0.170.32-0.380.29-0.620.040.12-0.62-0.070.43-0.20.27-0.28-0.33-0.030.09-0.150.280.22-0.16-0.34-0.290.13
-0.92-0.63-0.17-0.78-0.09-0.9-0.41-0.69-0.3-0.23-0.75-0.83-0.44-0.92-0.24-0.63-0.56-0.95-0.430.36-0.86-0.21-0.55-0.57-0.29
0.790.540.32-0.78-0.140.76-0.060.84-0.16-0.170.520.970.160.810.020.280.330.780.27-0.080.910.090.470.19-0.16
0.240.37-0.38-0.09-0.140.120.55-0.140.030.740.1-0.150.030.10.00.40.210.150.04-0.140.21-0.030.440.410.03
0.920.480.29-0.90.760.120.370.720.460.270.530.860.130.95-0.060.60.360.910.2-0.130.850.060.430.590.46
0.530.64-0.62-0.41-0.060.550.370.110.50.850.4-0.010.290.380.220.870.320.510.26-0.330.240.160.610.870.49
0.740.510.04-0.690.84-0.140.720.11-0.050.120.470.840.090.71-0.040.350.290.710.14-0.060.750.020.480.31-0.05
0.26-0.140.12-0.3-0.160.030.460.5-0.050.420.130.030.070.31-0.020.40.130.30.08-0.09-0.030.02-0.160.541.0
0.360.39-0.62-0.23-0.170.740.270.850.120.420.28-0.130.190.190.150.610.280.30.18-0.180.120.050.430.690.41
0.620.55-0.07-0.750.520.10.530.40.470.130.280.490.580.580.490.480.840.720.79-0.520.550.020.480.480.13
0.830.480.43-0.830.97-0.150.86-0.010.840.03-0.130.490.080.89-0.090.340.30.830.16-0.060.910.040.430.280.03
0.20.25-0.2-0.440.160.030.130.290.090.070.190.580.080.150.960.170.520.310.64-0.450.150.720.190.170.07
0.970.660.27-0.920.810.10.950.380.710.310.190.580.890.15-0.030.680.390.970.2-0.150.930.080.620.650.31
0.030.17-0.28-0.240.020.0-0.060.22-0.04-0.020.150.49-0.090.96-0.030.030.420.140.59-0.42-0.010.730.10.09-0.02
0.770.8-0.33-0.630.280.40.60.870.350.40.610.480.340.170.680.030.320.750.2-0.320.560.050.790.90.4
0.420.37-0.03-0.560.330.210.360.320.290.130.280.840.30.520.390.420.320.470.76-0.420.37-0.130.390.380.13
0.980.740.09-0.950.780.150.910.510.710.30.30.720.830.310.970.140.750.470.35-0.290.90.150.670.710.3
0.260.26-0.15-0.430.270.040.20.260.140.080.180.790.160.640.20.590.20.760.35-0.280.210.030.220.210.08
-0.22-0.30.280.36-0.08-0.14-0.13-0.33-0.06-0.09-0.18-0.52-0.06-0.45-0.15-0.42-0.32-0.42-0.29-0.28-0.12-0.26-0.16-0.2-0.09
0.930.720.22-0.860.910.210.850.240.75-0.030.120.550.910.150.93-0.010.560.370.90.21-0.120.090.690.47-0.03
0.110.16-0.16-0.210.09-0.030.060.160.020.020.050.020.040.720.080.730.05-0.130.150.03-0.260.090.060.070.02
0.720.95-0.34-0.550.470.440.430.610.48-0.160.430.480.430.190.620.10.790.390.670.22-0.160.690.060.7-0.16
0.720.69-0.29-0.570.190.410.590.870.310.540.690.480.280.170.650.090.90.380.710.21-0.20.470.070.70.54
0.26-0.140.13-0.29-0.160.030.460.49-0.051.00.410.130.030.070.31-0.020.40.130.30.08-0.09-0.030.02-0.160.54
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Arrowhead Pharmaceuticals has a Beta of 0.718. This is 16.51% lower than that of the Biotechnology sector and 48.35% lower than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

Arrowhead Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arrowhead Pharmaceuticals' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arrowhead Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arrowhead Pharmaceuticals by comparing valuation metrics of similar companies.
Arrowhead Pharmaceuticals is currently under evaluation in beta category among related companies.

Arrowhead Pharmaceuticals Current Valuation Drivers

We derive many important indicators used in calculating different scores of Arrowhead Pharmaceuticals from analyzing Arrowhead Pharmaceuticals' financial statements. These drivers represent accounts that assess Arrowhead Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Arrowhead Pharmaceuticals' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap1.6B2.6B4.3B3.5B3.1B3.3B
Enterprise Value1.6B2.4B4.2B3.5B3.1B3.3B

Arrowhead Pharmaceuticals Institutional Holders

Institutional Holdings refers to the ownership stake in Arrowhead Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Arrowhead Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Arrowhead Pharmaceuticals' value.
Shares
Capital Research & Mgmt Co - Division 32023-12-31
1.3 M
Northern Trust Corp2023-12-31
1.2 M
Rokos Capital Management Llp2023-12-31
1.2 M
Venbio Select Advisor Llc2023-12-31
1.1 M
Artal Group S A2023-12-31
M
Bank Of New York Mellon Corp2023-12-31
957.9 K
Ubs Asset Mgmt Americas Inc2023-12-31
951.3 K
Ameriprise Financial Inc2023-12-31
928.6 K
Woodline Partners Lp2023-12-31
927.2 K
Blackrock Inc2023-12-31
13.3 M
Vanguard Group Inc2023-12-31
10.7 M
As returns on the market increase, Arrowhead Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Arrowhead Pharmaceuticals is expected to be smaller as well.

Arrowhead Fundamentals

About Arrowhead Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Arrowhead Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arrowhead Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arrowhead Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Arrowhead Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Arrowhead Stock

  0.74ACB Aurora Cannabis TrendingPairCorr
  0.7XFOR X4 Pharmaceuticals Earnings Call This WeekPairCorr
  0.67CGC Canopy Growth Corp TrendingPairCorr
  0.6ELYM Eliem TherapeuticsPairCorr
  0.57NRSNW NeuroSense TherapeuticsPairCorr
The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals to buy it.
The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:
Check out Arrowhead Pharmaceuticals Piotroski F Score and Arrowhead Pharmaceuticals Altman Z Score analysis.
To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Arrowhead Stock analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is Arrowhead Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharmaceuticals. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.098
Earnings Share
(2.77)
Revenue Per Share
1.697
Quarterly Revenue Growth
(0.94)
Return On Assets
(0.25)
The market value of Arrowhead Pharmaceuticals is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharmaceuticals' market value can be influenced by many factors that don't directly affect Arrowhead Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arrowhead Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.